Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix") and Eos SENOLYTIX, Inc. ("Eos"), a biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related ...
Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy, achieving the ...
GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...
Mitochondria, once primarily recognized for their role in energy production, have emerged as crucial components in a wide ...
Stealth BioTherapeutics (the "Company"), a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial ...
A new mitochondrial capsule therapy delivers healthy mitochondria into cells with high efficiency. The approach restored ...
Almost every American has some degree of metabolic dysfunction — at least that’s what President Trump’s nominee for surgeon general would say. Dr. Casey Means, a graduate of the Stanford School of ...
Mitochondria are essential organelles that drive energy production, regulate apoptosis and orchestrate metabolic signalling within cells. Their dynamic nature underpins processes as diverse as ATP ...
Human cells have two copies of each chromosome, and this balance is essential for genes to be expressed in the appropriate ...
A study led by researchers at the USC Leonard Davis School of Gerontology suggests that the benefits of the Mediterranean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results